Meg Lashof-Sullivan, PhD is Director of R&D at PanTher Therapeutics. As a biomedical engineer with a background in biomaterials, Meg has expertise in polymer synthesis, drug delivery, and analytical laboratory techniques. She has led the transfer of PanTher’s PTM-101 from the academic laboratory to a clinical manufacturing process. She developed the in-house testing methods used to characterize the PTM-101 prototype and has overseen the external pre-clinical studies necessary to bring PTM-101 to the clinic.
Prior to joining PanTher Therapeutics, Meg completed her postdoctoral fellowship at The Henry M. Jackson Foundation for the Advancement of Military Medicine at the Naval Medical Research Center’s NeuroTrauma department. Before that,she served as a General Engineer at the U.S. Department of Energy.
Meg holds a PhD in Biomedical Engineering from Case Western Reserve University and both a BE in Engineering and BA in Biology and Engineering from Dartmouth College.